Careers
Vijayaganesh Kasinathan's Profile
B.Pharm, M.Pharm
Vijayaganesh, has completed his M. Pharm from Periyar college of Pharmaceutical Sciences in Trichy. He has five years of overseas experience working in Muscat and Qatar, as a pharmacist. He looks ahead to explore possibilities of safe medicine usage in space travel. His hobbies include traveling, view more..
Written / Edited / Medically Reviewed
Ertugliflozin Approved By US FDA for Treating Type 2 Diabetes
Ertugliflozin has been recently approved by US FDA for monotherapy and as a fixed dose combination to treat type 2 diabetes in adults.
Novel Peritoneal Dialysis (PD) Fluid Benefits Chronic Kidney Failure Patients
Alanyl-glutamine, a cytoprotective agent in dialysis fluid helps patients by reducing the risks in peritoneal dialysis.
Stem Cell Therapy in Perianal Fistula Associated with Crohn’s Disease
Perianal fistula which is a common complication of Crohn’s disease can now be treated with Darvadstrocel injection for faster healing.
Hydrocortisone Formulation Approved for Hormonal Disorder In Children
First pediatric hydrocortisone formulation has been granted approval for the treatment of primary adrenal insufficiency in children.
Discovering New Tuberculosis Drugs from Old Antibiotics
Tuberculosis along with other deadly microbial diseases can be easily treated effectively by future drugs simply by researching the existing antibiotics.
